샘플 요청 목록

 카트 문의
시장보고서
상품코드
1646767

세계의 후생유전학 시장

Epigenetics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 427 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

후생유전학 세계 시장 규모는 2030년까지 55억 달러에 달할 전망

2023년 17억 달러로 추정되는 후생유전학 세계 시장은 2030년에는 55억 달러에 달할 것으로 예상되며, 분석 기간인 2023-2030년 동안 17.9%의 CAGR로 성장할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 후생유전학 키트는 18.9%의 CAGR을 기록하여 분석 기간 종료 시점에 22억 달러에 도달할 것으로 예상됩니다. 후생유전학 시약 부문은 분석 기간 동안 18.0%의 CAGR로 성장할 것으로 예상됩니다.

미국 시장 6억 4,110만 달러로 추정, 중국은 CAGR 19.4%로 성장 전망

미국의 후생유전학 시장은 2023년 6억 4,110만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 5억 4,970만 달러의 시장 규모에 도달할 것으로 예상되며, 분석 기간인 2023-2030년 동안 CAGR은 19.4%에 달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 16.2% 및 17.7%의 CAGR을 기록할 것으로 예측됩니다. 유럽에서는 독일이 약 17.2%의 CAGR로 성장할 것으로 예상됩니다.

세계 후생유전학 시장 - 주요 동향 및 촉진요인 정리

후생유전학이란 무엇이며, 왜 현대 의학에 변화를 가져오는가?

후생유전학은 DNA 염기서열의 변화를 수반하지 않는 유전자 발현의 변화를 연구하는 학문입니다. 이러한 변화는 환경적 요인, 생활습관, 세포 내 신호의 영향을 받으며, DNA 메틸화, 히스톤 변형, 비암호화 RNA 상호작용과 같은 메커니즘을 통해 매개됩니다. 후생유전학은 발달, 노화, 질병 진행과 같은 생물학적 과정의 조절에 중요한 역할을 하고 있으며, 현대 의학의 혁신적인 연구 및 응용 분야가 되고 있습니다.

후생유전학의 변혁적 잠재력은 환경적 요인과 생활습관 선택이 유전자 발현과 건강 결과에 미치는 영향에 대한 인사이트를 제공하는 능력에 있습니다. 후생유전학적 변형은 유전자 변이와 달리 가역적이기 때문에 치료적 개입의 매력적인 표적이 될 수 있습니다. 예를 들어, 히스톤 탈아세틸화 효소(HDAC) 억제제나 DNA 메틸화 효소 억제제와 같은 후생유전학적 치료법은 암, 신경퇴행성 질환, 대사성 질환의 치료를 위해 개발되고 있습니다. 후생유전학적 메커니즘을 이해하고 이를 표적으로 삼음으로써 연구자들은 질병의 근본 원인을 다루는 맞춤형 치료법을 개발하여 정밀의료로 가는 길을 열 수 있습니다.

또한, 후생유전학은 진단학 및 의약품 개발에도 큰 영향을 미칩니다. 후생유전학적 바이오마커는 질병의 상태를 확인하고, 질병의 진행을 예측하고, 치료 효과를 모니터링하기 위해 점점 더 많이 사용되고 있습니다. 특정 메틸화 패턴과 같은 이러한 바이오마커는 암과 같은 질병의 조기 발견 및 비침습적 진단을 가능하게 합니다. 의약품 개발에서 후생유전학적 스크리닝을 통해 연구자들은 새로운 약물 표적을 발굴하고, 치료 전략을 최적화하며, 기술 혁신을 가속화하고, 환자 치료 결과를 개선할 수 있습니다. 유전학과 환경을 연결하는 가교로서 후생유전학은 건강과 질병에 대한 이해를 높이고 의료의 미래에 혁명을 일으킬 수 있는 핵심적인 역할을 하고 있습니다.

기술의 발전과 업계의 요구는 후생유전학 시장을 어떻게 형성하고 있는가?

시퀀싱, 이미징 및 계산 도구의 기술적 발전은 보다 정확하고 높은 처리량 및 확장 가능한 연구를 가능하게 하여 후생유전학 시장을 주도하고 있습니다. 전장유전체 바이설파이트 시퀀싱 및 ChIP-시퀀싱과 같은 차세대 시퀀싱(NGS) 기술은 연구자들이 유전체 전체의 DNA 메틸화 및 히스톤 변형을 매핑할 수 있게함으로써 후생유전학 연구에 혁명을 일으켰습니다. 이러한 도구는 전례 없는 해상도와 정확도를 제공하여 후생유전학적 변화가 유전자 조절과 질병 과정에 어떻게 영향을 미치는지 더 깊이 이해할 수 있게 해줍니다. 단일 세포 시퀀싱의 발전으로 연구자들은 단일 세포 수준에서 후생유전학적 변형을 분석할 수 있게 되었고, 조직과 종양의 세포 불균일성을 밝혀냄으로써 이러한 능력을 더욱 향상시킬 수 있게 되었습니다.

초 고해상도 현미경 및 고급 형광 이미징과 같은 고해상도 이미징 기술 또한 크로마틴 다이내믹스와 히스톤 변형을 실시간으로 시각화하여 연구에 변화를 가져오고 있습니다. 이러한 도구를 통해 과학자들은 후생유전학적 마크의 공간적 구성과 이들이 살아있는 세포 내 유전자 발현에 미치는 영향을 연구하여 후생유전학적 조절의 역동적인 특성에 대한 인사이트를 얻을 수 있습니다. 계산 알고리즘 및 AI 기반 분석과 결합하여 이미지 데이터와 시퀀싱 데이터를 통합하여 종합적인 후생유전학 지도를 생성하고, 유전자 거동과 질병 결과를 보다 정확하게 예측할 수 있습니다.

맞춤의료에 대한 수요가 증가하면서 업계가 표적 치료제와 진단법을 개발하기 위한 혁신적인 방법을 모색하면서 후생유전학 시장이 더욱 확대되고 있습니다. 후생유전학은 유전자 발현의 개인차와 질병 감수성을 이해하기 위한 프레임워크를 제공하여 맞춤형 중재법 개발을 가능하게 합니다. 예를 들어, 정밀 종양학은 후생유전학적 바이오마커를 활용하여 종양 특이적 변화를 식별하고 치료 결정을 내릴 수 있도록 돕습니다. 마찬가지로, 후생유전학적 데이터는 개인화된 생활습관 및 영양 권장사항을 설계하는 데 도움이 되어 예방적 건강관리를 지원합니다. 시퀀싱, 영상 진단, 맞춤형 의료의 발전은 현대 생의학 연구와 치료 혁신의 초석으로 후생유전학 시장의 성장을 주도하고 있습니다.

후생유전학이 가장 큰 영향을 미치는 산업 분야는 어디일까?

후생유전학은 종양학, 신경과학, 재생의학, 농업 등 다양한 산업 분야에 큰 영향을 미치고 있으며, 각 산업 분야는 이해, 진단 및 치료 접근법을 강화하는 데 큰 도움이 되고 있습니다. 종양학에서 후생유전학은 종양 성장, 전이 및 치료 저항성의 기저에 있는 후생유전학적 메커니즘을 밝혀냄으로써 암 연구와 치료에 혁명을 일으키고 있습니다. 을 재활성화하여 암세포를 화학요법에 민감하게 만드는 데 사용되고 있습니다. 또한, 후생유전학적 바이오마커는 암을 조기에 발견하고 개별화된 치료 전략을 가능하게 하여 환자의 예후를 개선하고 질병 부담을 줄일 수 있습니다.

신경과학에서 후생유전학은 알츠하이머병, 자폐증, 우울증과 같은 신경발달장애 및 신경퇴행성 질환의 분자 메커니즘에 대한 중요한 인사이트를 제공하고 있습니다. 히스톤 아세틸화 및 DNA 메틸화와 같은 후생유전학적 변형은 뇌의 가소성 및 기억 형성에 핵심적인 역할을 합니다. 연구자들은 이러한 변형을 표적으로 삼아 신경질환 치료 및 인지기능 회복을 위한 새로운 치료법을 개발하고 있습니다. 또한, 후생유전학은 정신건강에서 유전적 요인과 환경적 요인의 상호 작용을 조명하여 예방과 치료에 대한 전인적 접근법을 개발할 수 있게 해줍니다.

재생의학에서 후생유전학은 줄기세포 연구와 조직공학의 발전을 주도하고 있습니다. 다능성 유도와 같은 후생유전학적 초기화 기술을 통해 과학자들은 재생치료에 사용할 환자맞춤형 줄기세포를 생성할 수 있습니다. 이러한 줄기세포는 후생유전학적 상태를 조절하여 다양한 세포 유형으로 분화할 수 있어 당뇨병, 심혈관질환, 척수 손상과 같은 질병에 대한 맞춤형 치료법을 개발할 수 있습니다. 후생유전학은 또한 조직 재생의 효율을 높이고 인공조직의 안정성을 향상시키는 역할도 담당하고 있어 재생의료의 미래에 필수적인 역할을 하고 있습니다.

농업 분야에서 후생유전학은 식물이 가뭄, 더위, 병원균과 같은 환경적 스트레스 요인에 어떻게 반응하는지를 이해함으로써 작물의 회복력, 수확량, 품질을 향상시키는 데 활용되고 있습니다. 식물의 후생유전학적 변형은 변화하는 조건에 반응하여 유전자 발현을 조절하기 때문에 과학자들은 유전자 재조합 없이도 스트레스에 강한 작물 품종을 개발할 수 있습니다. 이러한 후생유전학적 접근법은 화학제품에 대한 의존도를 줄이고 기후변화에 직면한 식량 안보를 강화함으로써 지속가능한 농업에 기여할 수 있습니다. 이러한 분야에서 후생유전학은 혁신, 정밀성, 지속가능성을 지원하며, 광범위한 응용과 변화의 가능성을 강조하고 있습니다.

후생유전학 시장의 성장을 촉진하는 주요 요인은 무엇인가?

후생유전학 시장의 성장은 만성질환 및 복합질환의 유병률 증가, 맞춤의료에 대한 수요 증가, 연구 기술의 발전 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 암, 심혈관질환, 신경 퇴행성 질환과 같은 만성질환의 유병률 증가는 이들 질환이 후생유전학적 변형에 영향을 받는 경우가 많기 때문에 주요 촉진요인이 되고 있습니다. 후생유전학은 질병 메커니즘에 대한 인사이트를 제공하고, 치료 옵션이 제한적인 질병에 대한 치료 표적을 제공하며, 후생유전학 연구 및 의약품 개발에 대한 투자를 촉진합니다.

맞춤형 의료에 대한 수요 증가는 헬스케어가 질병에 걸리기 쉽고 치료에 대한 반응의 개인차를 다루는 맞춤형 접근 방식으로 전환하는 또 다른 중요한 원동력이 되고 있습니다. 후생유전학적 바이오마커는 환자 집단의 계층화를 가능하게 하고, 특히 종양학 및 희귀 유전질환에서 표적 치료제 개발을 유도합니다. 후생유전학적 데이터를 사용하여 치료 효과를 예측하고 질병의 진행을 모니터링하는 능력은 의료 개입의 정확성과 효과를 향상시키며, 정밀의료의 광범위한 트렌드와 일치합니다.

차세대 염기서열 분석, 단일세포 분석, 생물정보학 등 연구 기술의 발전도 시장을 견인하고 있습니다. 이러한 기술은 후생유전학적 제어의 복잡하고 역동적인 특성을 탐구하는 데 필요한 도구를 제공하여 이해와 적용에 있어 획기적인 발전을 가능하게 하며, AI와 머신러닝의 통합은 대규모 후생유전학적 데이터세트의 패턴과 상관관계를 파악하여 발견을 더욱 가속화할 수 있도록 돕습니다. 발견을 가속화합니다. 이러한 기술 발전은 연구 비용과 복잡성을 줄여 학술, 임상 및 상업적 기관이 보다 쉽게 이용할 수 있도록 돕고 있습니다.

질병 유행, 맞춤형 의료에 대한 수요, 기술 발전과 같은 촉진요인이 복합적으로 작용하여 후생유전학 시장의 성장을 촉진하고 있습니다. 각 산업계가 후생유전학적 지식을 활용하여 미충족 의료 수요를 충족시키고, 분야를 넘나드는 혁신을 지속하고 있는 가운데, 후생유전학은 헬스케어, 농업, 그리고 그 너머의 미래를 형성하는 데 핵심적인 역할을 할 준비가 되어 있습니다.

부문

제품(후생유전학 키트, 후생유전학 시약, 후생유전학 효소, 후생유전학 기기 및 소모품), 기술(DNA 메틸화 기술, 히스톤 메틸화 기술, 히스톤 아세틸화 기술, Large Non-Coding RNA 기술, MicroRNA 변형 기술, 크로마틴 구조 기술), 응용 분야(종양학 응용, 비종양학 응용)

조사 대상 기업 사례(주목 합계 95개사)

  • Abnova Corporation
  • Active Motif, Inc.
  • biomodal Ltd.
  • Bio-Rad Laboratories, Inc.
  • BPS Bioscience, Inc.
  • Creative Biogene
  • Creative Diagnostics
  • EpiCypher, Inc.
  • Epigentek Group Inc.
  • Fios Genomics Ltd.
  • Genomescan
  • Illumina, Inc.
  • Merck Millipore
  • New England Biolabs, Inc.
  • Novogene Co. Ltd.
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • Qiagen, Inc.
  • Revvity, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corporation

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm 25.02.14

Global Epigenetics Market to Reach US$5.5 Billion by 2030

The global market for Epigenetics estimated at US$1.7 Billion in the year 2023, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 17.9% over the analysis period 2023-2030. Epigenetics Kits, one of the segments analyzed in the report, is expected to record a 18.9% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Epigenetics Reagents segment is estimated at 18.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$641.1 Million While China is Forecast to Grow at 19.4% CAGR

The Epigenetics market in the U.S. is estimated at US$641.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$549.7 Million by the year 2030 trailing a CAGR of 19.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.2% and 17.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 17.2% CAGR.

Global Epigenetics Market - Key Trends & Drivers Summarized

What Is Epigenetics and Why Is It Transformative for Modern Medicine?

Epigenetics is the study of changes in gene expression that do not involve alterations to the underlying DNA sequence. These changes are influenced by environmental factors, lifestyle, and cellular signals and are mediated by mechanisms such as DNA methylation, histone modification, and non-coding RNA interactions. Epigenetics plays a crucial role in regulating biological processes, including development, aging, and disease progression, making it a transformative area of research and application in modern medicine.

The transformative potential of epigenetics lies in its ability to offer insights into how environmental factors and lifestyle choices affect gene expression and health outcomes. Epigenetic modifications are reversible, unlike genetic mutations, making them an attractive target for therapeutic intervention. For example, epigenetic therapies, such as histone deacetylase (HDAC) inhibitors and DNA methyltransferase inhibitors, are being developed to treat cancers, neurodegenerative disorders, and metabolic diseases. By understanding and targeting epigenetic mechanisms, researchers can develop personalized therapies that address the root causes of diseases, paving the way for precision medicine.

Additionally, epigenetics has a profound impact on diagnostics and drug development. Epigenetic biomarkers are increasingly being used to identify disease states, predict disease progression, and monitor treatment efficacy. These biomarkers, such as specific methylation patterns, enable early detection and non-invasive diagnostic methods for conditions like cancer. In drug development, epigenetic screening allows researchers to identify novel drug targets and optimize therapeutic strategies, accelerating innovation and improving patient outcomes. As a bridge between genetics and environment, epigenetics is central to advancing our understanding of health and disease and revolutionizing the future of medicine.

How Are Technological Advancements and Industry Demands Shaping the Epigenetics Market?

Technological advancements in sequencing, imaging, and computational tools are driving the epigenetics market by enabling more precise, high-throughput, and scalable research. Next-generation sequencing (NGS) technologies, such as whole-genome bisulfite sequencing and ChIP-sequencing, have revolutionized the study of epigenetics by allowing researchers to map DNA methylation and histone modifications across the genome. These tools provide unprecedented resolution and accuracy, enabling a deeper understanding of how epigenetic changes influence gene regulation and disease processes. Advances in single-cell sequencing further enhance these capabilities by allowing researchers to analyze epigenetic modifications at the single-cell level, uncovering cellular heterogeneity in tissues and tumors.

High-resolution imaging techniques, such as super-resolution microscopy and advanced fluorescence imaging, are also transforming epigenetics research by visualizing chromatin dynamics and histone modifications in real time. These tools allow scientists to study the spatial organization of epigenetic marks and their impact on gene expression within living cells, providing insights into the dynamic nature of epigenetic regulation. Combined with computational algorithms and AI-powered analytics, imaging and sequencing data can be integrated to generate comprehensive epigenetic maps, facilitating more accurate predictions of gene behavior and disease outcomes.

The increasing demand for personalized medicine is further shaping the epigenetics market as industries seek innovative ways to develop targeted therapies and diagnostics. Epigenetics provides a framework for understanding individual variations in gene expression and disease susceptibility, enabling the development of tailored interventions. For example, precision oncology leverages epigenetic biomarkers to identify tumor-specific modifications and guide treatment decisions. Similarly, epigenetic data informs the design of personalized lifestyle and nutritional recommendations, supporting preventive healthcare. Together, advancements in sequencing, imaging, and personalized medicine are driving the growth of the epigenetics market, making it a cornerstone of modern biomedical research and therapeutic innovation.

Where Is Epigenetics Making the Greatest Impact Across Industry Segments?

Epigenetics is making a significant impact across various industry segments, including oncology, neuroscience, regenerative medicine, and agriculture, each benefiting from enhanced understanding, diagnostics, and therapeutic approaches. In oncology, epigenetics is revolutionizing cancer research and treatment by uncovering the epigenetic mechanisms underlying tumor growth, metastasis, and resistance to therapy. Epigenetic therapies, such as HDAC inhibitors and DNA methyltransferase inhibitors, are being used to reactivate tumor suppressor genes and sensitize cancer cells to chemotherapy. Additionally, epigenetic biomarkers enable early cancer detection and personalized treatment strategies, improving patient outcomes and reducing the burden of disease.

In neuroscience, epigenetics is providing critical insights into the molecular mechanisms of neurodevelopmental and neurodegenerative disorders, such as Alzheimer’s disease, autism, and depression. Epigenetic modifications, including histone acetylation and DNA methylation, play a central role in brain plasticity and memory formation. By targeting these modifications, researchers are developing novel therapies to treat neurological conditions and restore cognitive function. Epigenetics also sheds light on the interplay between genetics and environmental factors in mental health, enabling the development of holistic approaches to prevention and treatment.

In regenerative medicine, epigenetics is driving advances in stem cell research and tissue engineering. Epigenetic reprogramming techniques, such as the induction of pluripotency, allow scientists to generate patient-specific stem cells for use in regenerative therapies. These stem cells can be differentiated into various cell types by modulating their epigenetic states, enabling the development of personalized treatments for conditions like diabetes, cardiovascular disease, and spinal cord injuries. Epigenetics also plays a role in enhancing the efficiency of tissue regeneration and improving the stability of engineered tissues, making it integral to the future of regenerative medicine.

In agriculture, epigenetics is being used to improve crop resilience, yield, and quality by understanding how plants respond to environmental stressors, such as drought, heat, and pathogens. Epigenetic modifications in plants regulate gene expression in response to changing conditions, enabling scientists to develop stress-tolerant crop varieties without genetic modification. These epigenetic approaches contribute to sustainable agriculture by reducing reliance on chemical inputs and enhancing food security in the face of climate change. Across these segments, epigenetics supports innovation, precision, and sustainability, highlighting its broad applications and transformative potential.

What Are the Key Drivers Fueling Growth in the Epigenetics Market?

The growth in the epigenetics market is driven by several key factors, including rising prevalence of chronic and complex diseases, increasing demand for personalized medicine, and advancements in research technologies. The rising prevalence of chronic diseases, such as cancer, cardiovascular conditions, and neurodegenerative disorders, is a primary driver as these conditions are often influenced by epigenetic modifications. Epigenetics provides insights into disease mechanisms and offers therapeutic targets for conditions with limited treatment options, driving investment in epigenetic research and drug development.

The increasing demand for personalized medicine is another significant driver, as healthcare shifts toward tailored approaches that address individual variations in disease susceptibility and response to treatment. Epigenetic biomarkers enable stratification of patient populations and guide the development of targeted therapies, particularly in oncology and rare genetic disorders. The ability to use epigenetic data to predict treatment efficacy and monitor disease progression enhances the precision and effectiveness of medical interventions, aligning with the broader trend of precision healthcare.

Advancements in research technologies, including next-generation sequencing, single-cell analysis, and bioinformatics, are also propelling the market. These technologies provide the tools needed to explore the complex and dynamic nature of epigenetic regulation, enabling breakthroughs in understanding and application. The integration of AI and machine learning further accelerates discoveries by identifying patterns and correlations in large epigenetic datasets. These technological advancements lower the cost and complexity of epigenetics research, making it more accessible to academic, clinical, and commercial entities.

Together, these drivers—disease prevalence, personalized medicine demand, and technological advancements—are fueling growth in the epigenetics market. As industries continue to leverage epigenetic insights to address unmet medical needs and innovate across sectors, epigenetics is poised to play a central role in shaping the future of healthcare, agriculture, and beyond.

SCOPE OF STUDY:

The report analyzes the Epigenetics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes, Epigenetics Instruments & Consumables); Technology (DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology, Chromatin Structures Technology); Application (Oncology Application, Non-Oncology Application)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 95 Featured) -

  • Abnova Corporation
  • Active Motif, Inc.
  • biomodal Ltd.
  • Bio-Rad Laboratories, Inc.
  • BPS Bioscience, Inc.
  • Creative Biogene
  • Creative Diagnostics
  • EpiCypher, Inc.
  • Epigentek Group Inc.
  • Fios Genomics Ltd.
  • Genomescan
  • Illumina, Inc.
  • Merck Millipore
  • New England Biolabs, Inc.
  • Novogene Co. Ltd.
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • Qiagen, Inc.
  • Revvity, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Human Quest for Supremacy Over Diseases Sets the Tone for Growth of Epigenetics as a Transformative Force in Healthcare
    • EXHIBIT 1: Medical Research is Sacrosanct & So is Epigenetics' Role as a Catalyst for Health Transformation: Global Pharmaceutical Research and Development Spending (In US$ Billion) for Years 2025, 2027, 2029, and 2031
    • Economic Frontiers: Trends, Trials & Transformations
    • EXHIBIT 2: In a World Torn by Geopolitical Instability & War, Steadfastness of Global GDP Becomes Increasingly Unpredictable Given the Many Direct and Indirect Economic Repercussions: World Economic Growth Projections (Real Gross Domestic Product (GDP), Annual % Change) for the Years 2022 Through 2025
    • EXHIBIT 3: All Eyes on Global Inflation, the Main Risk Factor in Global Markets: Global Headline Inflation Rates (In %) for the Years 2019 through 2025
    • EXHIBIT 4: With Oil Prices Influencing the Rate of inflation, it Remains the Most Watched Commodity in Global Markets: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2019 through 2025
    • Competition
    • EXHIBIT 5: Epigenetics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 95 Players Worldwide in 2024 (E)
    • What is Epigenetics? A Technical Rumination
    • Influencer/Product/Technology Insights
    • Recent Market Activity
    • Innovations
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Chronic Diseases Sets the Stage for Growth of Epigenetics
    • EXHIBIT 6: As Disease Burden Rises So Does the Value of Epigenetics in Understanding Diseases & Developing Cutting Edge Therapies: Need for Medicines: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2024 and 2030
    • Growing Focus on Understanding Inflammatory Musculoskeletal Diseases Brings Epigenetics Into the Spotlight
    • EXHIBIT 7: Growing Burden of Musculoskeletal Disorders (MSDs) Pins Hope on Epigenetics for Solutions: Global Prevalence of MSDs (In Million) for Years 2024, 2030, 2040 and 2050
    • Exponential Rise in Cancer Pins Hope on Epigenetic Therapies
    • EXHIBIT 8: Rising Cancer Burden Exerts Pressure on Epigenetics to Move Swiftly from Laboratory Studies and Clinical Trials to Precision Medicine: Global Incidence of Cancer (In Million) for Years 2020, 2030 and 2040
    • The Shift Towards Personalized Medicine Expands The Role Of Epigenetics
    • EXHIBIT 9: As Personalized Medicine Gains Momentum, New Doors of Opportunities Open for Epigenome-Based Personalized Medicine: Global Market for Personalized Medicine (In US$ Billion) for Years 2025, 2027, 2029, 2031 and 2033
    • A New Era for Epigenetic Studies Open with the Entry of Artificial Intelligence
    • EXHIBIT 10: The Potential for Applying Artificial Intelligence to Epigenetics is Just Emerging Supported by Growing AI Spending: Global Spending on AI in Healthcare (In US$ Billion) for Years 2025, 2027, 2029, 2031, and 2033
    • Advancements in Epigenome Editing Drives Growth in the Market
    • Focus on Crop Improvement Amid Climate Change Drives Up the Value of Epigenetics in Agriculture
    • EXHIBIT 11: Inverse Relationship Between Rising Temperatures Due to Emissions Induced Climate Change & Crop Productivity Drives Interest in Epigenetics for Plant Breeding: Global CO2 Emissions (In Billion Metric Tons) for Years 1960, 1970, 1980, 1990, 2000, 2010, 2020, 2021, 2022, 2023 and 2024
    • Ethical Issues Continue to Surround the Field of Epigenetics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Epigenetics Market Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 4: World 11-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2019, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Epigenetics Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Epigenetics Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 7: World 11-Year Perspective for Epigenetics Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Epigenetics Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Epigenetics Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 10: World 11-Year Perspective for Epigenetics Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Epigenetics Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Epigenetics Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 13: World 11-Year Perspective for Epigenetics Enzymes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Epigenetics Instruments & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Epigenetics Instruments & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 16: World 11-Year Perspective for Epigenetics Instruments & Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for DNA Methylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for DNA Methylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 19: World 11-Year Perspective for DNA Methylation Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Histone Methylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Histone Methylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 22: World 11-Year Perspective for Histone Methylation Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Histone Acetylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Histone Acetylation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 25: World 11-Year Perspective for Histone Acetylation Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Large Non-Coding RNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Large Non-Coding RNA Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 28: World 11-Year Perspective for Large Non-Coding RNA Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for MicroRNA Modification Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for MicroRNA Modification Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 31: World 11-Year Perspective for MicroRNA Modification Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Chromatin Structures Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Chromatin Structures Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 34: World 11-Year Perspective for Chromatin Structures Technology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 37: World 11-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Non-Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Non-Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 40: World 11-Year Perspective for Non-Oncology Application by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2019, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 41: USA Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 43: USA 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 46: USA 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 49: USA 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 52: Canada 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 55: Canada 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 58: Canada 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • JAPAN
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 61: Japan 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 64: Japan 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 67: Japan 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • CHINA
    • TABLE 68: China Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 70: China 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 73: China 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 76: China 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • EUROPE
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Epigenetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 79: Europe 11-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2019, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 82: Europe 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 85: Europe 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 88: Europe 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • FRANCE
    • TABLE 89: France Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 91: France 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 94: France 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 97: France 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • GERMANY
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 100: Germany 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 103: Germany 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 106: Germany 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 109: Italy 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 112: Italy 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 115: Italy 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • UNITED KINGDOM
    • TABLE 116: UK Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 118: UK 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 121: UK 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 124: UK 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • ASIA-PACIFIC
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Epigenetics by Product - Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 145: Rest of World 11-Year Perspective for Epigenetics by Product - Percentage Breakdown of Value Revenues for Epigenetics Kits, Epigenetics Reagents, Epigenetics Enzymes and Epigenetics Instruments & Consumables for the Years 2019, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Epigenetics by Technology - DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 148: Rest of World 11-Year Perspective for Epigenetics by Technology - Percentage Breakdown of Value Revenues for DNA Methylation Technology, Histone Methylation Technology, Histone Acetylation Technology, Large Non-Coding RNA Technology, MicroRNA Modification Technology and Chromatin Structures Technology for the Years 2019, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Epigenetics by Application - Oncology Application and Non-Oncology Application - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Epigenetics by Application - Oncology Application and Non-Oncology Application Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2019 through 2022 and % CAGR
    • TABLE 151: Rest of World 11-Year Perspective for Epigenetics by Application - Percentage Breakdown of Value Revenues for Oncology Application and Non-Oncology Application for the Years 2019, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제